CA-125 SECRETION BY PERITONEAL MESOTHELIAL CELLS

被引:120
作者
ZEILLEMAKER, AM [1 ]
VERBRUGH, HA [1 ]
VANPAPENDRECHT, AAGMH [1 ]
LEGUIT, P [1 ]
机构
[1] DIAKONESSEN HOSP,DEPT MED MICROBIOL,3582 KE UTRECHT,NETHERLANDS
关键词
D O I
10.1136/jcp.47.3.263
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To investigate the secretion of the tumour marker CA 125 by cultured human mesothelial cells; to determine if secretion of CA 125 could be observed by activating the mesothelial monolayers with different cytokines. Methods-Mesothelial cells were isolated from human omentum and cultured to confluent monolayers on perforated polycarbonate membranes (pore size 0.4 mu m). The mesothelial monolayers were activated and the apical and basolateral secretion of CA 125 compared. To investigate the influence of cytokines, mesothelial cells were cultured and activated with recombinant interleukin-1 beta (rIL-1 beta), tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide from Escherichia coli. The secretion of CA 125 was tested using a microparticle enzyme immunoassay. Results-Mesothelial monolayers secreted CA 125 in a polarised manner with preference for the apical side. Apical polarisation occurred irrespective of the side of the inducing stimulus (p less than or equal to 0.05). Non-activated cultured mesothelial monolayers secreted significant quantities of CA 125, indicating constitutive production of this protein. However, CA 125 production was significantly enhanced if mesothelial cells were incubated with rIL-1 beta (p less than or equal to 0.05), TNF-alpha (p less than or equal to 0.05), and E coli LPS (p less than or equal to 0.01). Conclusions-Human mesothelial monolayers secrete CA 125 preferentially from their apical surfaces. The secretion of CA 125 can be enhanced by the inflammatory cytokines II-1 beta, TNF-alpha, and by E coli LPS.
引用
收藏
页码:263 / 265
页数:3
相关论文
共 22 条
  • [1] NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS
    BAGGIOLINI, M
    WALZ, A
    KUNKEL, SL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) : 1045 - 1049
  • [2] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER
    BAST, RC
    KLUG, TL
    STJOHN, E
    JENISON, E
    NILOFF, JM
    LAZARUS, H
    BERKOWITZ, RS
    LEAVITT, T
    GRIFFITHS, CT
    PARKER, L
    ZURAWSKI, VR
    KNAPP, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) : 883 - 887
  • [3] REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA
    BAST, RC
    FEENEY, M
    LAZARUS, H
    NADLER, LM
    COLVIN, RB
    KNAPP, RC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) : 1331 - 1337
  • [4] BERGMANN JF, 1987, CANCER-AM CANCER SOC, V59, P213, DOI 10.1002/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO
  • [5] 2-I
  • [6] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER
    CANNEY, PA
    MOORE, M
    WILKINSON, PM
    JAMES, RD
    [J]. BRITISH JOURNAL OF CANCER, 1984, 50 (06) : 765 - 769
  • [7] REGULATION OF THE CYTOSKELETON IN MESOTHELIAL CELLS - REVERSIBLE LOSS OF KERATIN AND INCREASE IN VIMENTIN DURING RAPID GROWTH IN CULTURE
    CONNELL, ND
    RHEINWALD, JG
    [J]. CELL, 1983, 34 (01) : 245 - 253
  • [8] NEW CONCEPTS IN MOLECULAR-BIOLOGY AND ULTRASTRUCTURAL PATHOLOGY OF THE PERITONEUM - THEIR SIGNIFICANCE FOR PERITONEAL-DIALYSIS
    DOBBIE, JW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (02) : 97 - 109
  • [9] EINHORN N, 1986, OBSTET GYNECOL, V67, P414
  • [10] FLEUREN GJ, 1987, CANCER, V60, P2437, DOI 10.1002/1097-0142(19871115)60:10<2437::AID-CNCR2820601015>3.0.CO